MicroRNA-302 increases reprogramming efficiency via repression of NR2F2

Stem Cells

Volumn 31, Issue 2, 2013, Pages 259-268

  Hu, Shijun ^a,b   Wilson, Kitchener D ^b   Ghosh, Zhumur ^e   Han, Leng ^d   Wang, Yongming ^a,b,c   Lan, Feng ^a,b,c   Ransohoff, Katherine J ^b,c   Burridge, Paul ^a,b,c   Wu, Joseph C ^a,b,c,d  

^a Division of Cardiology   (United States)

^b The Cardiovascular Institute   (United States)

^c Center for Human Embryonic Stem Cell Research and Education   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSE INSTITUTE   (India)

Author keywords

Induced pluripotent stem cells; MicroRNA; OCT4; Reprogramming

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; MICRORNA 302; NR2F2 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEEDBACK SYSTEM; GENE EXPRESSION; GENE INTERACTION; GENE REPRESSION; HUMAN; HUMAN CELL; INTERACTIONS WITH RNA; KARYOTYPING; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; CELL DIFFERENTIATION; COUP TRANSCRIPTION FACTOR II; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES; MICROARRAY ANALYSIS; MICRORNAS; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS;

EID: 84874325911     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1278     Document Type: Article

References (69)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
2. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
3. Wilson KD, Venkatasubrahmanyam S, Jia F et al. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 2009;18: 749-758.
4. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
5. Jia F, Wilson KD, Sun N et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010;7:197-199.
6. Han JW, Yoon YS. Induced pluripotent stem cells: Emerging techniques for nuclear reprogramming. Antioxid Redox Signal 2011;15: 1799-1820.
7. Alcon A, Cagavi Bozkulak E, Qyang Y. Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci 2012;69:2635-2656.
8. Plath K, Lowry WE. Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011;12:253-265.
9. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012;481:295-305.
10. Tiscornia G, Vivas EL, Belmonte JC. Diseases in a dish: Modeling human genetic disorders using induced pluripotent cells. Nat Med 2011;17:1570-1576.
11. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956. (Pubitemid 41345211)
12. Marson A, Levine SS, Cole MF et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008;134:521-533.
13. Bernstein E, Kim SY, Carmell MA et al. Dicer is essential for mouse development. Nat Genet 2003;35:215-217. (Pubitemid 37363172)
14. Wang Y, Medvid R, Melton C et al. DGCR8 is essential for micro- RNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007;39:380-385. (Pubitemid 46328490)
15. Murchison EP, Partridge JF, Tam OH et al. Characterization of Dicerdeficient murine embryonic stem cells. Proc Natl Acad Sci USA 2005;102:12135-12140. (Pubitemid 41291141)
16. Stadler B, Ivanovska I, Mehta K et al. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 2010;19: 935-950.
17. Ren J, Jin P, Wang E et al. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 2009;7:20.
18. Xu N, Papagiannakopoulos T, Pan G et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009;137:647-658.
19. Miyoshi N, Ishii H, Nagano H et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011;8:633-638.
20. Rosa A, Brivanlou AH. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 2011;30:237-248.
21. Lin SL, Chang DC, Lin CH et al. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 2011;39:1054-1065.
22. Card DA, Hebbar PB, Li L et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008;28: 6426-6438.
23. Barroso-delJesus A, Lucena-Aguilar G, Sanchez L et al. The Nodal inhibitor lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J 2011;25:1497-1508.
24. Bunnell BA, Flaat M, Gagliardi C et al. Adipose-derived stem cells: Isolation, expansion and differentiation. Methods 2008;45:115-120. (Pubitemid 351885360)
25. Lewis BP, Shih IH, Jones-Rhoades MW et al. Prediction of mammalian microRNA targets. Cell 2003;115:787-798. (Pubitemid 38058492)
26. Griffiths-Jones S, Saini HK, van Dongen S et al. miRBase: Tools for microRNA genomics. Nucleic Acids Res 2008;36:D154-D158. (Pubitemid 351149713)
27. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
28. Hudson J, Titmarsh D, Hidalgo A et al. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev 2012;21:1513-1523.
29. Gonzalez R, Lee JW, Schultz PG. Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angew Chem Int Ed Engl 2011;50:11181-11185.
30. Han J, Yuan P, Yang H et al. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 2010;463:1096-1100.
31. Hu SJ, Ren G, Liu JL et al. MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem 2008;283: 23473-23484.
32. Hu S, Huang M, Li Z et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010;122:S124-S131.
33. Hu S, Huang M, Nguyen PK et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 2011;124:S27-S34.
34. Liu H, Deng S, Zhao Z et al. Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells. Mol Biol Rep 2011;38: 2155-2160.
35. Ben-Shushan E, Sharir H, Pikarsky E et al. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor: retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol Cell Biol 1995;15:1034-1048.
36. Schoorlemmer J, van Puijenbroek A, van Den Eijnden M et al. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol Cell Biol 1994;14:1122-1136. (Pubitemid 24036563)
37. Subramanyam D, Lamouille S, Judson RL et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011;29:443-448.
38. Sun N, Panetta NJ, Gupta DM et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009;106:15720-15725.
39. Lin SL, Chang DC, Chang-Lin S et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008;14: 2115-2124.
40. Lipchina I, Elkabetz Y, Hafner M et al. Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev 2011;25:2173-2186.
41. Rosa A, Spagnoli FM, Brivanlou AH. The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell 2009;16:517-527.
42. Pollard SM, Conti L, Sun Y et al. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex 2006;16(suppl 1): i112-i120,
43. Conti L, Pollard SM, Gorba T et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 2005;3:e283.
44. Wang Z, Oron E, Nelson B et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012;10:440-454.
45. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-582. (Pubitemid 351253686)
46. Ivanova N, Dobrin R, Lu R et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006;442:533-538. (Pubitemid 44167907)
47. Mallanna SK, Rizzino A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev Biol 2010;344:16-25.
48. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010;463: 621-626.
49. Foshay KM, Gallicano GI. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 2009;326:431-443.
50. van Rooij E. Introduction to the series on microRNAs in the cardiovascular system. Circ Res 2012;110:481-482.
51. Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res 2012;94:284-292.
52. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011;91:827-887.
53. Ambros V. MicroRNAs and developmental timing. Curr Opin Genet Dev 2011;21:511-517.
54. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G et al. Embryonic stem cell-specific miR302-367 cluster: Human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008;28:6609-6619.
55. Tarasov KV, Tarasova YS, Tam WL et al. B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One 2008;3:e2478.
56. Boheler KR. Stem cell pluripotency: A cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle. J Cell Physiol 2009;221:10-17.
57. Zhu W, Giangrande PH, Nevins Jr. E2Fs link the control of G1/S and G2/M transcription. EMBO J 2004;23:4615-4626. (Pubitemid 39657861)
58. Shi W, Wang H, Pan G et al. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J Biol Chem 2006;281:23319-23325. (Pubitemid 44274106)
59. Pereira FA, Tsai MJ, Tsai SY. COUP-TF orphan nuclear receptors in development and differentiation. Cell Mol Life Sci 2000;57: 1388-1398.
60. Martin LJ, Tremblay JJ. Nuclear receptors in Leydig cell gene expression and function. Biol Reprod 2010;83:3-14.
61. Hubert MA, Sherritt SL, Bachurski CJ et al. Involvement of transcription factor NR2F2 in human trophoblast differentiation. PLoS One 2010;5:e9417.
62. Vilhais-Neto GC, Maruhashi M, Smith KT et al. Rere controls retinoic acid signalling and somite bilateral symmetry. Nature 2010;463: 953-957.
63. Naka H, Nakamura S, Shimazaki T et al. Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development. Nat Neurosci 2008;11:1014-1023.
64. Lin FJ, Chen X, Qin J et al. Direct transcriptional regulation of neuropilin- 2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 2010;120:1694-1707.
65. Yamazaki T, Yoshimatsu Y, Morishita Y et al. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 2009;14:425-434.
66. Anokye-Danso F, Trivedi CM, Juhr D et al. Highly efficient miRNAmediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011;8:376-388.
67. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009;136:215-233.
68. Lin SL, Chang DC, Ying SY et al. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 2010; 70:9473-9482.
69. Lee NS, Kim JS, Cho WJ et al. miR-302b maintains ''stemness'' of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Biochem Biophys Res Commun 2008;377: 434-440.